Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020)-Reference-Cited by-同舟云学术

Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020)

Published:2021-01-21 Issue:7 Volume:15 Page:885-898
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Sachdeva Kuldeep Singh¹,Parmar Malik²^ORCID,Patel Yogesh³^ORCID,Gupta Ritu⁴,Rathod Sandeep³^ORCID,Chauhan Sandeep³^ORCID,Anand Sridhar⁵,Ramachandran Ranjani⁶

Affiliation:

1. Deputy Director General – Tuberculosis, Central TB Division, New Delhi, India

2. National Professional Officer (Drug Resistant & Latent TB), WHO Country Office, New Delhi India

3. National Consultant (DR–TB), WHO NTEP Technical Support Network, New Delhi, India

4. Additional DDG – TB, Central TB Division, New Delhi, India

5. National Consultant (TB Laboratories), WHO NTEP Technical Support Network, New Delhi, India

6. National Professional Officer (TB & Laboratories), WHO Country Office, New Delhi, India

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2021.1850277

Reference52 articles.

1. WHO. Global Tuberculosis Report 2020 [Internet] . 2020. [accessed 2020 Nov 3]. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf

2. Surveillance of drug resistance in tuberculosis in two districts of South India

3. Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2008: RNTCP Status Report [Internet]. Available from: https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807

4. Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD.National Anti-TB Drug Resistance Survey.pdf [Internet] 2018.[accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/showfile.php?lid=3315

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress and challenges in achieving tuberculosis elimination in India by 2025: A systematic review and meta-analysis;PLOS ONE;2024-03-27

2. Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis;International Journal of Infectious Diseases;2021-10